Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
2
×
abaloparatide
akero therapeutics
amgen
apellis pharmaceuticals
aragon pharmaceuticals
boston
boston blog main
clinical trials
corey goodman
europe blog main
europe top stories
european commission
fda
financing
funding
harmony biosciences
investment
m&a
national
osteoporosis
pfizer
precision biosciences
radius health
romosozumab
san francisco blog main
san francisco top stories
startups
teriparatide
turning point therapeutics
ucb
venbio
venture capital
What
medicine
2
×
risk
2
×
amgen
amgen’s
approach
approval
bags
biotechs
capital
carries
developed
drug
europe
european
heart
investing
investors
led
limited
making
marketing
mitigated
new
nod
osteoporosis
partners
raise
recession
venbio
venture
warning
wins
worried
Language
unset
Current search:
risk
×
medicine
×
" national blog main "
×
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
